Senti Biosciences
SNTI · South San Francisco, CA
Works in Cardiovascular · Dermatology · Hematology · Immunology · Oncology
Senti Biosciences is a clinical trial sponsor based in South San Francisco, CA, listed as SNTI. It has 1 active clinical trial with 21 planned participants, across 5 therapeutic areas.
Trial track record · since 2021
Financials · SNTI
Fundraising
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Senti Biosciences
Senti Biosciences is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 21 planned participants, in Cardiovascular, Dermatology, Hematology, Immunology and other areas. Since 2021 it has completed 0 trials and stopped 0 early.
Senti Biosciences is based in South San Francisco, CA and is listed as SNTI. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Senti Biosciences; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-02-12.
Approve Suite is not affiliated with Senti Biosciences. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.